Description: Joe Wurzburger, Staff Fellow at the SOA, shares his views and insights about the health care industry in general and the Health Section's role in particular.

Description: Interview with Paul Ginsburg, president of the Center for Studying Health System Change.

Description: The big event of 2023 is the launch of multiple Humira biosimilars, which began in January with the arrival of Amgen’s Amjevita on the market. The launch of Amjevita kicks off the process of changing the specialty drug marketplace in the United States. The expectation of the full impact of this big event is very hopeful, but there is still uncertainty several months after its beginning. Humira is the highest-selling drug in the world and has been since 2013 (Figure 1)—except for when COVID-19 projects temporarily surpassed it. The world is eagerly awaiting the launch of multiple biosimilar drugs to compete with Humira and hopefully bring more competitive pricing to the benefit of payers and patients everywhere.

Description: How benchmarking actual performance to a published source is a useful tool in assessing the value added by a particular program or MCO, Issue No. 38.

Description: This article discusses the impact for MACRA legislation that will impact the Medicare Supplement market in 2020 and the ramifications for Med Supp carriers

Description: Mining Electronic Health Records using a Natural Language Processor.

Description: This article summarizes the 2016 SOA Annual Meeting and Exhibit from a Health Section perspective.

Description: The interview discusses the ACA exchange intiatives program, a strategic project of the SOA focusing on ACA marketplace emerging data and actuarial principles

Description: Read the February 2018 issue of Health Watch, published by the Health Section. Practical information for actuaries, articles impact sections, section activities.

Description: Joe Wurzburger, Staff Fellow at the SOA, shares his views and insights about the health care industry in general and the Health Section's role in particular.